News

Article

Australian Society of Ophthalmologists announces new board appointments

Key Takeaways

  • The ASO has appointed three new board members to enhance advocacy and efficiency within the organization.
  • Rahul Chakrabarti and Tricia Drew bring extensive ophthalmology expertise to the ASO Board, while Mark Grey is the first board member with vision impairment.
SHOW MORE

Incoming directors bring diverse expertise to help the ASO protect ophthalmic care and advocate for patients.

(Image credit: StockAdobe/Andrija)

(Image credit: StockAdobe/Andrija)

The Australian Society of Ophthalmologists (ASO) has welcomed three new members to its Board of Directors in a move to strengthen advocacy and efficiency within the organization.1

Rahul Chakrabarti, MBBS (Hons), BMedSc (Hons), MD, MSurgED (Hons), FRANZCO

Rahul Chakrabarti, MBBS (Hons), BMedSc (Hons), MD, MSurgED (Hons), FRANZCO

Rahul Chakrabarti, MBBS (Hons), BMedSc (Hons), MD, MSurgED (Hons), FRANZCO, and Tricia Drew, MBBS, BMedSci (Hons) PhD, FRANZCO, will join representative Mark Grey, from Tasmania.

ASO President Peter Sumich, MBBS (Hons), FRANZCO, highlighted the unique strengths each new director brings, emphasizing the organization’s evolving role in addressing critical health care challenges.

Chakrabarti is comprehensive general ophthalmologist at The Royal Victorian Eye and Ear Hospital in East Melbourne, Australia, and the Essendon Eye Clinic. He is director of ophthalmology training for RANZCO in Victoria, Australia.

Tricia Drew, MBBS, BMedSci (Hons) PhD, FRANZCO

Tricia Drew, MBBS, BMedSci (Hons) PhD, FRANZCO

Drew is a consultant ophthalmologist and Chair of the Eye Section, senior medical staff at The Royal Victorian Eye and Ear Hospital in East Melbourne, Australia. She is the RANZCO Younger Fellows Advisory Group State Representative for Victoria.

Mark Grey

Mark Grey

Grey’s appointment marks a milestone as the first person with vision impairment to serve on the ASO Board, according to the organization.

“We have been in a period of peacekeeping for some time but are seeing this shift as various issues across Australian health care are reaching a crisis point,” Sumich said. “With advocacy playing an essential role in the year ahead, we are pleased to announce these appointments and reaffirm that our voice — the voice of Australian ophthalmologists and their patients — is growing stronger.”

Founded in 1982, the ASO is a leader in medico-political advocacy, working to ensure excellence in ophthalmology care and equitable access to services for all Australians, according to the organization.

Reference
  1. ASO welcomes new year with incoming Board appointments. News release. Australian Society of Ophthalmologists. February 19, 2025. Accessed February 25, 2025. https://www.asoeye.org/index.cfm?module=news&pagemode=indiv&page_id=2778022

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.